A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C

Investigational New Drugs

from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/2qNzNb4
via IFTTT